A Phase I Clinical Trial of Irinotecan and Carboplatin in Patients with Extensive Stage Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase I Clinical Trial of Irinotecan and Carboplatin in Patients with Extensive Stage Small Cell Lung Cancer

Published:2012 Issue:4 Volume:58 Page:257-263
ISSN:1421-9794
Container-title:Chemotherapy
language:en
Short-container-title:Chemotherapy

Author:

Crabb Simon J.,Bradbury Jennifer,Nolan Luke,Selman Diana,Muthuramalingam Sethupathi R.,Cave Judith,Johnson Peter W.M.,Ottensmeier Christian

Publisher

S. Karger AG

Subject

Infectious Diseases,Pharmacology (medical),Drug Discovery,Pharmacology,Oncology,General Medicine

Reference16 articles.

1. Small Cell Lung Cancer: Past, Present, and Future

2. Twenty Years of Phase III Trials for Patients With Extensive-Stage Small-Cell Lung Cancer: Perceptible Progress

3. A national survey of the chemotherapy regimens used to treat small cell lung cancer (SCLC) in the United Kingdom

4. Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weekly irinotecan combined with carboplatin for patients with small-cell lung cancer: A phase I study;Respiratory Investigation;2015-07

2. Interaction of human organic anion transporter 2 (OAT2) and sodium taurocholate cotransporting polypeptide (NTCP) with antineoplastic drugs;Pharmacological Research;2015-01

3. In vivo biodistribution of platinum-based drugs encapsulated into multi-walled carbon nanotubes;Nanomedicine: Nanotechnology, Biology and Medicine;2014-10

4. Human Herpesvirus 6 Encephalitis Simulating Brain Metastases in a Patient with Advanced Small-Cell Lung Cancer;Chemotherapy;2013

5. Gefitinib Enhances the Antitumor Activity of CPT-11 in vitro and in vivo by Inhibiting ABCG2 but Not ABCB1: A New Clue to Circumvent Gastrointestinal Toxicity Risk;Chemotherapy;2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3